Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ALUR
ALUR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALUR News
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Allurion Technologies Shares Decline Amid Warrant Concerns
Feb 25 2026
Benzinga
U.S. Stocks Rise with Dow Jones Up Over 400 Points
Feb 24 2026
Benzinga
Allurion Technologies Announces Warrant Exercise Agreement
Feb 24 2026
seekingalpha
U.S. Stocks Mixed in Morning Trade; Dow Jones Up Over 100 Points
Feb 24 2026
Benzinga
Allurion Technologies Announces Immediate Exercise of Warrants
Feb 24 2026
Newsfilter
U.S. Stocks Decline as Dow Jones Drops Over 700 Points
Feb 23 2026
Benzinga
Allurion Smart Capsule Receives FDA Approval
Feb 23 2026
stocktwits
U.S. Stocks Mixed in Morning Trade; Energy Shares Rise
Feb 23 2026
Benzinga
Allurion Secures FDA Approval, Paving New Path in Obesity Treatment
Feb 23 2026
Newsfilter
Allurion Technologies Inc. Receives FDA Approval for Gastric Balloon System
Feb 23 2026
moomoo
Consumer Discretionary Stocks with Low Momentum and High Valuation
Feb 03 2026
seekingalpha
Allurion Achieves 23% Weight Loss with Low-Dose Tirzepatide Combination
Nov 25 2025
Newsfilter
Zacks Industry Outlook Spotlights Boston Scientific, Insulet, BioLife Solutions, and Allurion
Nov 18 2025
NASDAQ.COM
Allurion Technologies, Inc. (ALUR) Announces Q2 Loss and Falls Short of Revenue Projections
Aug 19 2025
NASDAQ.COM
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS
Jun 17 2025
Newsfilter
Show More News
